Spasticity Treatment Market Size, Share and Industry Analysis with Trends, Forecasts 2019-2025
Spasticity Treatment Market Size, Share and Industry Analysis By Type (Drug Therapy, Physical and Occupational Therapy, Surgery, and Others), By Product (Baclofen, Benzodiazepines, Dantrolene Sodium, Imidazolines, Gabapentin, and Botulinum Toxin (BTA) Injections), By End User (Hospitals and Clinics, Rehabilitation Centers, and Other End Users), By Region (North America, Europe, Asia-Pacific, and Rest of the World), Competitive Market Share & Forecast, 2019 - 2025
The global spasticity treatment market is expected to reach USD xxx million by 2025 from USD xxx million in 2018, at a CAGR of xx% during the forecast period. Global Spasticity treatment market report covers market size, market share and market forecast by type, end user, regions, and key players, with historical data along with forecast from 2019 to 2025. The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Spasticity Treatment Market Outlook:
Spasticity is a medical condition in which certain muscles are continuously contracted. This continuous contraction causes stiffness or tightness of the muscles and can interfere with the normal movement, speech and posture. Spasticity is commonly caused by significant damage to the portion of brain or the spinal cord that controls one’s voluntary movement. It may also occur along with spinal cord injury, brain or head trauma, amyotrophic lateral sclerosis, multiple sclerosis, hereditary spastic paraplegias, cerebral palsy, stroke, and metabolic diseases such as adrenoleukodystrophy, phenylketonuria, and Krabbe disease. This damage to the brain or spinal cord results in changing balance of signals between the nervous system and the muscles. Spasticity is a condition that negatively affects the muscles and joints of the extremities and mainly causes harm to the growing children.
Diagnosis and treatment of spasticity depends on the severity of the spasticity and disorders associated with it. Treatment alternative of spasticity may include such medications as baclofen, diazepam, tizanidine or clonazepam. Along with products, the spasticity treatment market also consists of various therapeutic services such as physical therapy, speech therapy, and so on. Physical therapy treatments include muscle stretching and number of motion exercises which help prevent shrinkage or shortening of muscles. These therapies also help to reduce the severity of symptoms. Moreover, targeted injection of botulinum toxin administered into muscles with the most damage can help to selectively weaken these muscles to improve range of motion and function. In many cases surgeries are also recommended which would help in tendon release or to sever the nerve-muscle pathway. These and many such treatment alternatives collaboratively contribute to the existing market size of the spasticity treatment industry.
Spasticity Treatment Market Trends and Advancements:
Spasticity is a common health condition which affects people with long term neurological conditions such as multiple sclerosis, stroke, and traumatic brain and spinal cord injuries. If not treated in time, spasticity can result in severe complications, such as pressure sores, skin breakdown, urinary tract infections, and painful limb contractures. As this condition is commonly observed worldwide, large number research organizations in the spasticity treatment market are conducting continuous research studies to develop and analyse new and innovative treatment alternatives. For instance, in 2014 clinical trials were conducted to study the advances in treatment and management of multiple sclerosis spasticity. Moreover, introduction of neurostimulation devices is one of the key trends that is expected to gain traction in the spasticity treatment market. Number of companies are developing neurostimulation devices to overcome the adverse effects associated with drugs therapy by treating spasticity in combination with the available medications. For instance, in April 2016 PathMaker Neurosciences announced launch of clinical trial, in partnership with Northwell Health to evaluate the safety and efficacy of MyoRegulator for the treatment of spasticity.
In addition to drug therapy, various non-pharmacological therapies are also being developed and launched in the spasticity treatment market. Scientists conducted research studies and provided a review of new technologic advances in neuro-rehabilitative treatments for spasticity in 2017. These studies were conducted to analyse the effects of physical and occupational therapies provided for spasticity assessment and treatment. Such studies concluded that inclusion of physical and occupational therapies in treatment of spasticity are likely to improve the patient’s condition and prevent them from adverse reactions associated with the drugs consumed. These and many such studies focus on developing alternative treatments that would increasing the market size of the spasticity treatment market and also provide significant growth opportunities to the players operating this market on local and global level.
Spasticity Treatment Market Drivers and Restraints:
Globally, the popularity of physical therapy is drastically increasing, which acts as one of the key factors driving the growth of global spasticity treatment market. Patients worldwide are increasingly adopting physical and occupational therapy treatment for spasticity because it has minimal side effects. Furthermore, several advantages associated with physiotherapy are encouraging various hospitals to invest in a physiotherapy centers. Along with this factors such as presence of advanced drug delivery technology, growing investment development of therapeutic alternatives, and development of stimulatory devices built in with advanced technologies are also expected to fuel the growth of spasticity treatment market during the forecast period. However, factors such as time required to gain results of physical therapy, and adverse effects associated with drugs administered are likely to hinder the market growth during the forecast period.
Spasticity Treatment Market Segmentation and Geographic Outlook:
The spasticity treatment market is segmented on the basis of type, end user and geography. On the basis of type, the market is segmented into drug therapy, physical and occupational therapy, surgery, and others. Drug therapy consists of baclofen, benzodiazepines, dantrolene sodium, imidazolines, gabapentin, and botulinum toxin (BTA) injections. By end user the spasticity treatment market is segmented into hospitals and clinics, rehabilitation centers, and other end users. Geographic breakdown and deep analysis of each of the segments mentioned above is included for North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to dominate the market by holding maximum market share of the global spasticity treatment market. However, Asia-Pacific is expected to experience a fastest growth during the forecast period. Growing demand for effective therapies and increasing prevalence of spasticity are the major factors contributing to the growth of spasticity treatment market in this region.
Spasticity Treatment Market Competitive Landscape:
The spasticity treatment market appears to be moderately fragmented and with the presence of several emerging and established vendors. The companies operating in the market are focusing on developing products such as neurostimulation devices to treat spasticity in combination with medications available. Also, the companies are forming strategic alliances with government organizations to create awareness regarding the symptoms and treatment alternative available for spasticity. Such activities enable the companies to mark their presence and gain significant market share in the global spasticity treatment market.
A comprehensive and competitive analysis of market leaders is provided in this report. Some of the major players operating in the global spasticity treatment market include Allergan, F. Hoffmann-La Roche Ltd., Ipsen Pharma, Pfizer Inc., UCB S.A., Codman & Shurtleff, Inc., Medtronic, Inc., InMed Pharmaceuticals, Inc., and Orient Pharma Co., Ltd.
What you get from the Spasticity Treatment Market Research Report:
· The study provides an in-depth analysis of the spasticity treatment market with current and future trends to explain the imminent investment pockets in the market
· Current and future trends are outlined to determine the overall attractiveness and to single out profitable trends to gain a stronger foothold in the market
· The report provides information regarding key drivers, restraints and opportunities with impact analysis
· Quantitative analysis of the current market and estimations through 2018-2025 are provided to showcase the financial caliber of the market
· Porters Five Forces model and SWOT analysis of the industry illustrates the potency of the buyers & suppliers participating in the market
· Value chain analysis in the report provides a clear understanding of the roles of stakeholders involved in the value chain
Choose License Type
Why Choose Us
24/5 Research support
Get your queries resolved from an industry expert.
Custom research service
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.